Umbrella Labs BPC157 Liquid Spray Peptide Research Use Only Program Expands Access For High Rigor Regenerative Biology, Gastrointestinal, And Tissue Repair Bench Science TUCSON, AZ / ACCESS Newswire / January 29, 2026 / Umbrella Labs today announced expanded availability of its BPC-157 liquid spray peptide format for laboratory developmental research use only, supporting controlled preclinical and in vitro investigations where repeatable dispensing and clear documentation matter
Fixed costs of $50,000 come from the top section (cell D7)
Hospira offers products ranging from basic drug dilutions to complex infusion therapy, and provides products that meet strict safety requirements for sterile and parenteral use
The peptide reduced weight loss, improved disease activity scores, decreased colonic inflammation, and promoted mucosal repair through modulation of the SIRT1/STAT3 signaling pathway
Success requires physician supervision, objective body composition monitoring (not just scale weight), and integration with proper nutrition and exercise foundations for optimal metabolic outcomes
